Design, Synthesis, and Biological Evaluation of Tetrahydro-α-carbolines as Akt1 Inhibitors That Inhibit Colorectal Cancer Cell Proliferation

ChemMedChem. 2022 Jun 3;17(11):e202200104. doi: 10.1002/cmdc.202200104. Epub 2022 Apr 19.

Abstract

A series of densely functionalized THαCs were designed and synthesized as Akt1 inhibitors. Organocatalytic [3+3] annulation between indolin-2-imines 1 and nitroallylic acetates 2 provided rapid access to this pharmacologically interesting framework. In vitro kinase inhibitory abilities and cytotoxicity assays revealed that compound 3 af [(3S*,4S*)-4-(4-bromo-2-fluorophenyl)-9-methyl-3-nitro-1-tosyl-2,3,4,9-tetrahydro-1H-pyrido[2,3-b]indole] was the most potent Akt1 inhibitor, and mechanistic study indicated that compound 3 af suppressed the proliferation of colorectal cancer cells via inducing apoptosis and autophagy. Molecular docking suggested that the indole fragment of 3 af was inserted into the hydrophobic pocket of Akt1 protein, and the H-bond between 3 af and residue Lys179 also contributed to the stable binding. This article provides an efficient strategy to design and synthesize biologically important compounds as novel Akt1 inhibitors.

Keywords: Akt1 inhibitor; Anti-cancer compound; Molecular docking; Organocatalytic reaction; Tetrahydro-α-carboline.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Carbolines / chemistry
  • Cell Proliferation
  • Colorectal Neoplasms* / drug therapy
  • Humans
  • Indoles / chemistry
  • Indoles / pharmacology
  • Molecular Docking Simulation
  • Proto-Oncogene Proteins c-akt
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Carbolines
  • Indoles
  • alpha-carboline
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt